The effect of active immunization against nicotine on the initial distribut
ion of nicotine to brain was studied in anesthetized rats. Animals received
nicotine 0.03 mg/kg nicotine (equivalent to the nicotine dose absorbed by
a human smoking two cigarettes) as a rapid injection in the jugular vein. I
n control animals, the arterial serum nicotine concentration initially exce
eded the venous concentration 4.6-fold, similar to the initial arteriovenou
s difference produced by cigarette smoking in humans. Animals immunized wit
h the nicotine analog CMUNic maintained this arteriovenous gradient. but wi
th both arterial and venous nicotine concentrations several times higher th
an in controls. The arterial nicotine concentration was higher in immunized
animals even at the first (7.5 s) sampling time. The brain nicotine concen
tration at 3 min was 36% lower in the immunized animals. The time course of
nicotine distribution to brain was studied in a second group of animals. B
rain nicotine concentration was reduced in rats immunized with CMUNic over
the entire 6-min sampling period immediately following nicotine dosing (mea
n reduction 38%). A reduction was found at the earliest sampling time (30 s
) and was maximal at 1 min (48%). Nicotine protein binding in serum was mar
kedly increased in animals immunized with CMUNic compared to controls (91.2
versus 10.9%), and the unbound nicotine concentration in serum was lower (
10.0 versus 13.4 ng/ml). The reduction in brain nicotine concentration corr
elated with antibody affinity for nicotine, and the percentage of nicotine
bound in serum, These data demonstrate that nicotine-specific antibodies pr
oduced by active immunization rapidly bind nicotine in arterial blood, redu
ce the unbound nicotine concentration, and reduce the early distribution of
nicotine to brain, Effects were observed using a clinically relevant nicot
ine dose and route of administration. These data suggest that the use of im
munization to modify the behavioral effects of nicotine may be possible.